Merck
MRK
$79.29
Share price
1.29%
Change (1 day)
-38.05%
Change (1 year)
Categories
Merck (MRK) - Net assets
Net assets on the balance sheet as of March 2025 : $48.40 Billion USD
According to Merck's latest financial reports the company has $48.40 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Merck - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$46.37 B | 23.22% |
| 2023-12-31 | $$37.63 B | -18.29% |
| 2022-12-31 | $$46.05 B | 20.39% |
| 2021-12-31 | $$38.25 B | 50.59% |
| 2020-12-31 | $$25.40 B | -2.3% |
| 2019-12-31 | $$26.00 B | -3.28% |
| 2018-12-31 | $$26.88 B | -22.24% |
| 2017-12-31 | $$34.56 B | -14.24% |
| 2016-12-31 | $$40.30 B | -9.96% |
| 2015-12-31 | $$44.76 B | -8.25% |
| 2014-12-31 | $$48.79 B | -6.76% |
| 2013-12-31 | $$52.32 B | -5.66% |
| 2012-12-31 | $$55.46 B | -2.6% |
| 2011-12-31 | $$56.94 B | 0.24% |
| 2010-12-31 | $$56.80 B | -7.61% |
| 2009-12-31 | $$61.48 B | 190.47% |
| 2008-12-31 | $$21.16 B | 2.8% |
| 2007-12-31 | $$20.59 B | 3.13% |
| 2006-12-31 | $$19.96 B | -2.06% |
| 2005-12-31 | $$20.38 B | 3.5% |
| 2004-12-31 | $$19.69 B | 1.04% |
| 2003-12-31 | $$19.49 B | -15.73% |
| 2002-12-31 | $$23.12 B | 10.73% |
| 2001-12-31 | $$20.88 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $90.63 B | 87.27% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $78.10 B | 61.38% | 🇺🇸 USA |
 Eli Lilly LLY | $15.84 B | -67.26% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $17.44 B | -63.95% | 🇺🇸 USA |
 Sanofi SNY | $80.54 B | 66.42% | 🇫🇷 France |
 GlaxoSmithKline GSK | $17.66 B | -63.50% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $6.26 B | -87.05% | 🇮🇱 Israel |
 Novartis NVS | $38.45 B | -20.55% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $49.06 B | 1.37% | 🇺🇸 USA |
 Amgen AMGN | $6.20 B | -87.18% | 🇺🇸 USA |